BIP
ABBV icon

Blueprint Investment Partners’s AbbVie ABBV Stock Holding History

Blueprint Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,847
Closed -$861K – 97
2024
Q4 		$861K Sell
4,847
-1,932
-28% -$355K 0.14% 83
2024
Q3 		$1.34M Buy
6,779
+2,001
+42% +$373K 0.24% 56
2024
Q2 		$820K Sell
4,778
-2,327
-33% -$385K 0.18% 60
2024
Q1 		$1.29M Buy
7,105
+2,868
+68% +$494K 0.26% 51
2023
Q4 		$657K Buy
4,237
+1,621
+62% +$236K 0.18% 60
2023
Q3 		$390K Buy
+2,616
New +$384K 0.13% 80
2023
Q2 		– Sell
-4,479
Closed -$714K – 144
2023
Q1 		$714K Sell
4,479
-6,611
-60% -$1.01M 0.16% 83
2022
Q4 		$1.79M Buy
11,090
+4,997
+82% +$766K 0.38% 60
2022
Q3 		$818K Sell
6,093
-2,166
-26% -$311K 0.22% 64
2022
Q2 		$1.26M Buy
8,259
+2,793
+51% +$427K 0.34% 51
2022
Q1 		$886K Buy
5,466
+691
+14% +$100K 0.23% 76
2021
Q4 		$647K Buy
4,775
+1,565
+49% +$185K 0.16% 101
2021
Q3 		$346K Buy
+3,210
New +$367K 0.17% 87
2021
Q2 		– Sell
-1,944
Closed -$210K – 76
2021
Q1 		$210K Buy
+1,944
New +$208K 0.16% 64

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Blueprint Investment Partners's ABBV Position: Q1 2025 in Review

Blueprint Investment Partners sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 4,847 shares — an estimated $861K sold.

Blueprint Investment Partners first reported a position in ABBV in Q1 2021 and held it in 14 quarters. The position peaked at $1.79M in Q4 2022. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Blueprint Investment Partners reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Blueprint Investment Partners sold 4,847 AbbVie shares in Q1 2025, an estimated $861K.
  • Blueprint Investment Partners first reported a position in AbbVie in Q1 2021 and held it in 14 quarters.
  • Blueprint Investment Partners's AbbVie position peaked at $1.79M in Q4 2022.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Blueprint Investment Partners's 13F filing for Q1 2025, filed 12 May 2025.